Research Record

• PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B Journal of Hepatology, 2024, v.80 no.1, 20-30
  SCIE Scopus dColl.
• The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study Diagnostics, 2024, v.14 no.1, 14
  SCIE Scopus dColl.
• Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification Metabolites, 2023, v.13 no.3, 444
  SCIE Scopus dColl.
• Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial Trials, 2023, v.24 no.1, 490
  SCIE Scopus dColl.
• Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study The American journal of gastroenterology, 2023, v.118 no.11, 1963-1972
  SCIE Scopus dColl.
• Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease Clinical Gastroenterology and Hepatology, 2023, v.21 no.9, 2298-2.31E21
  SCIE Scopus dColl.
• TM4SF5-mediated abnormal food-intake behavior and apelin expression facilitate non-alcoholic fatty liver disease features iScience, 2023, v.26 no.9, 107625
  SCIE Scopus dColl.
• Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease International Journal of Molecular Sciences, 2023, v.24 no.11, 9324
  SCIE Scopus dColl.
• An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B JOURNAL OF HEPATOLOGY, 2022, v.76 no.2, 311-318
  SCIE Scopus dColl.
• Association of Chronic Hepatitis B Infection and Antiviral Treatment with the Development of the Extrahepatic Malignancies: A Nationwide Cohort Study Journal of Clinical Oncology, 2022, v.392, 1285
  SCIE Scopus dColl.
• Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease Clinical Gastroenterology and Hepatology, 2022
  SCIE Scopus dColl.
• Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B Clinical Gastroenterology and Hepatology, 2022, v.20 no.6, 1343-1.35E19
  SCIE Scopus dColl.
• Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration Journal of Clinical Medicine, 2022, v.11 no.9, 2463
  SCIE Scopus dColl.
• Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B CANCERS, 2021, v.13 no.14, 3424
  SCIE Scopus dColl.
• Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression Journal of Pathology, 2021, v.253 no.1, 55-67
  SCIE Scopus dColl.
• Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study Digestive Diseases and Sciences, 2021, v.66 no.7, 2427-2438
  SCIE Scopus dColl.
• Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma YONSEI MEDICAL JOURNAL, 2021 , 12-20
  SCIE Scopus KCI dColl.
• Recent advances in nonalcoholic fatty liver disease metabolomics CLINICAL AND MOLECULAR HEPATOLOGY, 2021, v.27 no.4, 553-559
  SCIE Scopus KCI dColl.
• Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis CLINICAL AND MOLECULAR HEPATOLOGY, 2021, v.27 no.4, 535-552
  SCIE Scopus KCI dColl.
• A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function BMC CANCER, 2020, v.20 no.1, 504
  SCIE Scopus dColl.
• Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study GUT, 2020, v.69 no.12, 2214-2222
  SCIE Scopus dColl.
• Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease BMC NEPHROLOGY, 2020, v.21 no.1, 50
  SCIE Scopus dColl.
• Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease Scientific Reports, 2020, v.10 no.1, 17491
  SCIE Scopus dColl.
• 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma KOREAN JOURNAL OF RADIOLOGY, 2019, v.20 no.7, 1042-
  SCIE Scopus KCI dColl.
• Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects PLOS ONE, 2019, v.14 no.3, e0213692
  SCIE Scopus dColl.
• Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices JOURNAL OF HEPATOLOGY, 2019, v.70 no.3, 412-422
  SCIE Scopus dColl.
• Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial JOURNAL OF HEPATOLOGY, 2019, v.70 no.4, 684-691
  SCIE Scopus dColl.
• The Efficacy of Cone-Beam CT–Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization Journal of Vascular and Interventional Radiology, 2019, v.30 no.3, 358-369
  SCIE Scopus dColl.
• Tumor marker-based definition of the transarterial chemoembolization-refractoriness in intermediate-stage hepatocellular carcinoma: A multi-cohort study Cancers, 2019, v.11 no.11, 1721
  SCIE Scopus dColl.
• A Model for Adaptive Decision Making of 'Ablate-and-Wait' Versus Transplantation in Patients with Hepatocellular Carcinoma Journal of Clinical Gastroenterology, 2018, v.52 no.7, 655-661
  SCIE Scopus dColl.
• Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality Scientific Reports, 2018, v.8 no.1, 13651
  SCIE Scopus dColl.
• Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial TRIALS, 2018, v.19, 696
  SCIE Scopus dColl.
• Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, v.47 no.11, 1490-1501
  SCIE Scopus dColl.
• Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study BMC CANCER, 2018, v.18
  SCIE Scopus dColl.
• Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study JOURNAL OF MEDICAL VIROLOGY, 2018, v.90 no.10, 1593-1603
  SCIE Scopus dColl.
• Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib CANCER RESEARCH AND TREATMENT, 2018, v.50 no.2, 366-373
  SCIE Scopus KCI dColl.
• Current immunotherapeutic strategies in hepatocellular carcinoma: Recent advances and future directions Therapeutic Advances in Gastroenterology, 2017, v.10 no.10, 805-814
  SCIE Scopus dColl.
• Noninvasive prediction of hemodynamic response to carvedilol therapy for primary prophylaxis in cirrhotic patients with esophageal varices: a prospective study JOURNAL OF HEPATOLOGY, 2017, v.66 no.1, S47-S47
  SCIE Scopus dColl.
• Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients PLOS ONE, 2017, v.12 no.1
  SCIE Scopus dColl.
• 소라페닙 치료 실패 후 반복적인 경동맥 화학색전술로 장기 생존한 1예 대한간암학회지, 2017, v.17 no.1, 82~87
  KCI후보 dColl.
• A Novel Biomarker-Based Model for the Prediction of Response to Sorafenib and Overall Survival for Advanced Hepatocellular Carcinoma: A Prospective Cohort Study HEPATOLOGY, 2016, v.63 no.1 SUPP, 634A-634A
  SCIE Scopus dColl.
• Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome MEDICINE, 2016, v.95 no.2, e2454
  SCIE Scopus dColl.
• Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, v.31 no.2, 427-433
  SCIE Scopus dColl.
• Characterization of gastrointestinal hemorrhage and prediction of mortality in Asian patients with alcoholic hepatitis JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, v.31 no.4, 814-821
  SCIE Scopus dColl.
• Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders! Gut and Liver, 2016, v.10 no.6, 869
  SCIE Scopus KCI dColl.
• Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders! GUT AND LIVER, 2016, v.10 no.6, 869-870
  SCIE Scopus KCI dColl.
• Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria ANNALS OF SURGERY, 2016, v.263 no.5, 842-850
  SCIE Scopus dColl.
• Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay GUT AND LIVER, 2015, v.9 no.5, 657-664
  SCIE Scopus KCI dColl.
• Prospective Comparison of Noninvasive Fibrosis Assessment to Predict Advanced Fibrosis or Cirrhosis in Asian Patients With Hepatitis C JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, v.49 no.8, 697-704
  SCIE Scopus dColl.
• Reduction of Oxidative Stress Attenuates Lipoapoptosis Exacerbated by Hypoxia in Human Hepatocytes INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, v.16 no.2, 3323-3334
  SCIE Scopus dColl.
• The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic Patients MEDICINE, 2015, v.94 no.24, e1031
  SCIE Scopus dColl.
• Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease MEDICINE, 2015, v.94 no.48, e2159
  SCIE Scopus dColl.
• MicroRNA-196A-2 Polymorphisms and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B JOURNAL OF MEDICAL VIROLOGY, 2014, v.86 no.3, 446-453
  SCIE Scopus dColl.
• [학술지논문] An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B JOURNAL OF HEPATOLOGY, 2022, v.76 no.2 , 311-318
  SCI
• [학술지논문] Association of Chronic Hepatitis B Infection and Antiviral Treatment With the Development of the Extrahepatic Malignancies: A Nationwide Cohort Study JOURNAL OF CLINICAL ONCOLOGY, 2022, v.40 no.29 , 3394-+
  SCI
• [학술지논문] Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, v.20 no.6 , 1343-+
  SCIE
• [학술지논문] Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration JOURNAL OF CLINICAL MEDICINE, 2022, v.11 no.9 , 2463-2463
  SCIE
• [학술지논문] Recent advances in nonalcoholic fatty liver disease metabolomics Clinical and molecular hepatology, 2021, v.27 no.4 , 553-559
  SCIE
• [학술지논문] Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma Clinical and molecular hepatology, 2020, v.26 no.2 , 238-239
  SCIE
• [학술지논문] Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease SCIENTIFIC REPORTS, 2020, v.10 no.1 , 17491-17491
  SCI
• [학술지논문] Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study CANCERS, 2019, v.11 no.11 , 1721-1721
  SCIE

Academic Background